Hyperthyroidism in pregnancy: design and methodology of a Danish multicenter study
Abstract Background Graves’ disease (GD) is the main cause of hyperthyroidism in women of the fertile age. In pregnant women, the disease should be carefully managed and controlled to prevent maternal and fetal complications. Observational studies provide evidence of the adverse effects of untreated...
Main Authors: | Nanna Maria Uldall Torp, Inge Bülow Pedersen, Allan Carlé, Jesper Scott Karmisholt, Eva Ebbehøj, Diana Grove-Laugesen, Thomas Heiberg Brix, Steen Joop Bonnema, Bieke F. Schrijvers, Birte Nygaard, Lena Bjergved Sigurd, Ulla Feldt-Rasmussen, Marianne Klose, Åse Krogh Rasmussen, Stig Andersen, Stine Linding Andersen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | Thyroid Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13044-023-00154-8 |
Similar Items
-
Graves’ hyperthyroidism in pregnancy: a clinical review
by: Caroline T. Nguyen, et al.
Published: (2018-03-01) -
Therapeutic Management and Long-Term Outcome of Hyperthyroidism in Patients with Antithyroid-Induced Agranulocytosis: A Retrospective, Multicenter Study
by: Carlos García Gómez, et al.
Published: (2023-10-01) -
Two Cases of Methimazole-Induced Agranulocytosis With Their Risk Factors
by: Aye Khine, MD, et al.
Published: (2022-03-01) -
Agranulocytosis: a rare complication of the thionamides
by: Hawa Juma El-Shareif
Published: (2023-08-01) -
Risk of congenital anomalies associated with antithyroid treatment during pregnancy: a meta-analysis
by: Xiang Li, et al.
Published: (2015-06-01)